XPH / XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Car more_horizontal

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively mana more_horizontal

Making its debut on 06/19/2006, smart beta exchange traded fund SPDR S&P Pharmaceuticals ETF (XPH) provides investors broad exposure to the Health Car more_horizontal

XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive more_horizontal

If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the SPDR S&P Pharmaceuticals ETF more_horizontal

Launched on 06/19/2006, the SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs ca more_horizontal

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the more_horizontal

Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively mana more_horizontal